David H Frager, MD

Locations

Mount Sinai West

1000 Tenth Avenue, New York, NY, 10019

212-523-7048

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:21

Article:41

Review Article:3

Letter:1

Editorial:1

Recent Artifacts

• Computed tomography findings of internal hernia after gastric bypass that may precede small bowel obstruction
• Nongynecological endometriosis presenting as an acute abdomen
• Internal hernia complications of gastric bypass surgery in the acute setting: Spectrum of imaging findings
• Cost-effectiveness and patient tolerance of low-attenuation oral contrast material: Milk versus volumen
• Bilateral massive renal angiomyolipomatosis in tuberous sclerosis
• Biweekly low-dose sequential gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (GFP): A highly active novel therapy for metastatic adenocarcinoma of the exocrine pancreas
• Intestinal obstruction role of CT
• Large mesenteric lipoma ultrasonographically mimicking a mature cystic teratoma during pregnancy
• An unusual case of diverticulitis complicating pregnancy at 33 weeks' gestation
• Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Frager did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.